SPY Archives - Page 170 of 170 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Options Ideas, Bottom-Play & More

Kraig BioCraft Laboratories, Inc. KBLB

Despite an overall lag in the markets yesterday, due in part to the Greek financial crisis, KBLB did manage a brief surge right out of the starting gate. We tagged it for its attractiveness with regard to its positioning on the chart as well as the interesting news that was released; the company claims to have synthesized a material which is stronger than spider silk. (>>View PR)

The stock traded in a range from its opening price of .0365 up to a high of .05 inside of the first ten minutes, which marked a 37% rip.

While KBLB failed to maintain that early increase, the nature of yesterday’s news alone will cause us to reserve a spot on our watchlist for this play. If the company has indeed developed a super-material as they’ve described, it could ultimately be a game-changer in everything from the medical field, to space exploration, and nanotechnology.

Viscount Systems, Inc. VSYS

VSYS it hitting our radar as a potential bottom play with a potential news catalyst hitting presswires this morning.

VANCOUVER, BC / ACCESSWIRE / June 30, 2015 / Viscount Systems, Inc. (“Viscount”) (OTCQB:VSYS), a software company specializing in physical and logical security solutions, today announced that it has fully retired a convertible note held by Vis Vires Group, Inc. The convertible promissory note was issued to Viscount on March 30, 2015 at a principal amount of $169,000 bearing interest at 8% per annum and was used to resolve short term liquidity issues. >> Full PR

New Options Ideas

There’s a fair amount of uncertainty with respect to how the markets will react to the ongoing fiscal turmoil in Greece. They appear to want to rebound this morning, but it could be a false positive. It leads us to a familiar scenario, where uncertain conditions open avenues of opportunity to intuitive traders.

What we’re going to do is sit on the fence and observe SPY 205.50-207 Puts and Calls to start out with, and decide where the action will be once the overall market sentiment has been firmly established. It’s a strategy that’s served us well in the past.

_____

We’re also going to be monitoring JUNO $60-$63.50 Calls as the stock is gapping up heavily in the premarket.

Extended Watchlist:
AMD, AEZS, LBIO, DSKX, SFUN

Blue Horseshoe Stocks: Wrapping Up Another Great Week

The Priceline Group, Inc. PCLN – Options

After honing in on PCLN options last week as the Expedia/Orbitz buyout was calling massive attention to the sector, we were able find significant gain opportunities. This week, we were treated to continued upward momentum courtesy of Priceline’s earnings release, and the chances to profit have once again been plentiful.

Yesterday morning, we formulated a daytrading idea to watch Weekly PCLN Calls in the $1180-1225 range, and we were not disappointed in the price action that followed. Any of the contracts in that range would have served traders well. :

At the low end of the spectrum the $1180’s traded in a daily range from $24-42, an intraday increase of 75%, while the action closer to the money, like the $1220 Calls, was even more intense. As you can see on the screenshot below, there were multiple swings in those contracts. They first dipped to a low of 3.35 before exploding to 8.30 (+147%) followed by another pullback to 4.00 and a subsequent run back to 8.80 (+120%).

Ascent Solar Technologies, Inc. ASTI

Another big performer from yesterday’s pool of tracked stocks was ASTI. After tagging it in our premarket extended watchlist the stock registered an early low of 1.36 and ran hard in the last hour of trading, touching a high of 2.08. That represented an intraday increase of 53%, and it came on roughly 16x the 3mo. average volume.

CollabRx, Inc. CLRX

Also standing out on yesterday’s report was CLRX, which ran hard out of the gate and made an initial move from 1.67-2.74. That worked out to a spike of 64%, also on heavy volume.

Side Note:

After so much upward momentum, the overall markets could be looking at a pullback today, and even amid a hefty downturn there should still be options opportunities on the table. If that is indeed the case we may be taking a look at potential trades of SPY $210 Puts, or $22 UVXY Calls.

Extended Watchlist:
CRC, MEIP, CLSN, EPRS, SAAS

Blue Horseshoe Stocks: Options Review, MKHD Recap

Reviewing Friday’s Options Calls

First thing today, we’d like to rehash a portion of Friday’s report that we didn’t get a chance to discuss yesterday. Our regular followers will recall the added note we included regarding a few options trading ideas we were considering. As a result of favorable jobs numbers released that morning, we pointed out our interest in trading Calls in SPY, AA, ISRG, & GPRO.

Regardless of which selection one used to take advantage of the trend, it was met with potentially lucrative results. The dip-and-rip pattern we were on the lookout for showed itself across the board. For example, one of the biggest standouts out of the bunch were the SPY $195 weekly calls had traded as low as .52, and made it to roughly 2.00.

Moving forward, we’ve got another set of options to monitor. One of our favorite options trading cash-cows this year has been PBR, and yesterday the stock had a big bounce following last week’s selloff. As a result we’re going to radar November $16 Calls, and see if we can once again use PBR to our advantage as we have countless times already this year.

Mount Knowledge Holdings, Inc. MKHD

After a significant performance following our first mention of MKHD (Range: .042-.085 +102%) the stock has done a good job of maintaining higher levels of support, and we just wanted to re-state why we are so keen to follow this light volume trader.

The thing that mainly drew us to MKHD last week was the PR the company released regarding its acquisition of cyber-security firm Civergy, Inc; an outfit which generated revenues in excess of $35M last year. Further details of the deal were released in an 8-K on Wednesday, and we’re anxious to see what kind of lasting effect the merger will have on MKHD.

Extended Watchlist:
GTAT, GSAT, BCLI, ISR (Bottom Play)

Blue Horseshoe Stocks: RSH Update & More

Radio Shack Corp. RSH

RSH has made regular appearances in our reports over the past couple of months, starting in the beginning of August, when we caught the stock off of its 52-week low of .55.

Following a major run-up to the 1.60-range on August 29th, the stock has been under a general consolidation amid bankruptcy rumors. This week, the company was hinting at possible refinancing deal that would allow them to avoid that situation for the time being, and this morning, that deal was confirmed.

As a result, the stock is up significantly today, having traded as high 1.65 in the premarket. We’re going to want to see support hold at previous resistance points at 1.15 and 1.30. Already, at today’s early highs, we’re seeing more than a 100% increase off of the lows we observed following our most recent RSH alert (.80)

Rockwell Medical, Inc. RMTI

RMTI is another morning gapper that we’re going to place on watch today. With the stock coming off of a recent bottom, it’s going to be interesting to see how today’s development affects its price action.

The company put out a hefty PR this morning regarding a commercialization/distribution deal with Baxter Healthcare (BAX):

WIXOM, Mich., Oct. 3, 2014 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.>> VIEW PR

BioCryst Pharmaceuticals, Inc. BCRX

BCRX appeared on Wednesday in our extended watchlist, and what has followed has been two fruitful sessions in a row. From a low of 9.89 on Wednesday, we witnessed as the stock bulled its way into yesterday’s close, reaching a daily high of 11.49, a solid 16% overnight increase.

Inovio Pharmaceuticals, Inc. INO

Speaking of pharma plays, INO, a stock that has appeared several times in our reports recently, is also making moves concurrently with the present concern over the Ebola virus outbreak. The company actually has a Ebola vaccine with which they’ve reported success in treating animals with the deadly virus. Anything to do with Ebola is getting a lot of attention at present, and INO is no exception.

Side Note:

Jobs numbers were out this morning, to a positive reception. We will subsequently be looking for dip-and-rip opportunities with regard to options trading. Friday is characteristically a day when premiums start to come down as a result of time decay, with expirations looming. We’re looking at potential opportunities trading Calls in plays like SPY, AA, ISRG, & GPRO.

Extended Watchlist:
HALO, JBLU, WAVX, IAG, SFUN, NXTD